These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2203313

  • 21. Activity of meropenem, against gram-positive bacteria.
    Kayser FH, Morenzoni G, Strässle A, Hadorn K.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
    [Abstract] [Full Text] [Related]

  • 22. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ, Yang YJ, Livermore DM.
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [Abstract] [Full Text] [Related]

  • 23. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR.
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of CGP 31608, a new penem.
    Wise R, Andrews JM, Piddock LJ.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640.
    Tanaka M, Hohmura M, Nishi T, Sato K, Hayakawa I.
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1260-8. PubMed ID: 9174181
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G, Schrinner E.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
    [Abstract] [Full Text] [Related]

  • 39. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
    Watanabe Y, Hatano K, Matsumoto Y, Tawara S, Yamamoto H, Kawabata K, Takasugi H, Matsumoto F, Kuwahara S.
    J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
    [Abstract] [Full Text] [Related]

  • 40. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R, Andrews JM, Cross C, Piddock LJ.
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.